Project Grant 60NANB24D123
Award Date
8/15/24
Completion Date
8/15/25
Dollars Obligated
$963K
Federal Agency
National Institute of Standards and Technology
Federal Grant Program
11.617
Assistance Type
Project Grant
Place of Performance
Fort Lauderdale, FL 33328, USA
Similar Awards
This $1,920,000 federal Project Grant award, funded by the National Institute of Standards and Technology (NIST) under the Congressionally-Identified Projects program (CFDA 11.617), supports Ferris State University in Big Rapids, Michigan. The primary objectives are to purchase and integrate critical equipment, including a 500 MHz NMR spectrometer, generator(s), benchtop LCMS, flow cytometer, and other laboratory instruments. Additionally, the university will hire a lab technician to develop...
The National Institute of Standards and Technology (NIST) awarded a $955,000 Project Grant under the Congressionally-Identified Projects program (CFDA 11.617) to HMH Hospitals Corporation in Edison, NJ. The grant establishes a nanopore long-read DNA sequencing capability as a core facility within the HMH Center for Discovery and Innovation. Specific equipment and technologies to be procured include the PromethION high-throughput and GridION medium-throughput sequencing systems, along with...
This $949,116 Project Grant awarded by the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) will fund the acquisition of a Thermo Fisher Scientific Orbitrap IQ-X mass spectrometer system with a Vanquish Flex UHPLC system at the University of South Florida (USF). This cutting-edge analytical instrumentation will establish a unique omics capability at USF to support detailed, high-resolution structural analysis of low-level small molecules in complex...
This $274,594 Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports research and development of an innovative technology for cancer diagnosis and treatment. The project aims to improve molecular profiling and clinical laboratory testing of cancer samples by optimizing microdissection techniques. The research will focus on modeling and optimizing the opto-thermal-mechanical interactions involved in microdissection to...
This $900,000 Project Grant was awarded on September 1, 2024 by the National Institute of Standards and Technology (NIST) under the Congressionally-Identified Projects (CFDA 11.617) program. The grant's purpose is to procure research equipment needed to establish the Pathogen Research and Surveillance Laboratory at the University of Central Florida (UCF). Specifically, the grant will enable UCF to purchase automated sample preparation and next-generation genomic sequencing equipment. This...
The National Institute of Standards and Technology (NIST) awarded a $2,440,000 Project Grant under the Congressionally-Identified Projects program (CFDA 11.617) to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The purpose of this grant is to fund the acquisition of high-precision microscopes to image cells deep within 3D tumor models. These microscopes will enable the researchers to detect and measure millions of cells within a single tumor,...
The National Institute of Standards and Technology (NIST) awarded a $963,000 Project Grant (CFDA 11.617 - Congressionally-Identified Projects) to the University of St. Thomas to purchase five analytical instruments: (1) a $495,000 microfocus computer tomography system, (2) a $163,000 inductively-coupled plasma mass spectrometry system, (3) a $183,000 matrix-assisted laser desorption/ionization mass spectroscopy system, (4) a $86,000 size-exclusion chromatography/gel permeation chromatograph, and...
This Project Grant award of $749,901.00, provided by the National Institute of Environmental Health Sciences (CFDA 93.113 Environmental Health), supports research to elucidate the origins of mutational landscapes in cancer. The key objectives are to: Generate DNA samples and use mass spectrometry to characterize the DNA adductome (types and amounts of DNA lesions) from exposure to environmental mutagens like 1,2,3-trichloropropane, bromochloroacetic acid, and furan. Map the genomic positions...
This Project Grant award from the National Institutes of Health (NIH) Research Infrastructure Programs (CFDA 93.351) provides $1,035,125.00 to the Dana-Farber Cancer Institute (DFCI) to acquire a NovaSeq X Plus high-throughput DNA sequencing system. This instrument will be integrated into DFCI's Molecular Biology Core Facilities (MBCF) to expand their genomics services, including whole genome sequencing, methylation profiling, single-cell genomics, and spatial transcriptomics. The increased...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Cerflux Inc. aims to develop a personalized cancer treatment screening platform. The project will establish guidelines for handling solid tumor biopsy samples, generate 3D bioprinted tumor models for validation, and demonstrate the platform's ability to match patients with the most effective cancer treatments before treatment begins. This innovative approach has the...